Yao HM, Jones SR, Morales S, Moosavi S, et al. Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer. Cancer Chemother Pharmacol 2021 Oct 7. pii: 10.1007/s00280-021-04355.
PMID: 34618197